Iopamidol for myelography. A clinical trial with a new non-ionic contrast medium.
289 myelographies with the non-ionic, water-soluble, contrast medium iopamidol were performed. These were subdivided into 153 lumbar, 49 ascending thoracocervical and 87 cervical myelographies. For the latter a lateral C1-C2 puncture was used. The iodine concentration given was 200 mg/ml for the lumbar examinations and 300 mg/ml for the cervical and thoraco-cervical examinations. The total iodine never exceeded 3 g. Image quality is not different to metrizamide of equal iodine concentration. Adverse reactions did not exceed those known for metrizamide. Mild and transient side effects occured in 45%.
D002986:Clinical Trials as Topic; D003287:Contrast Media; D005260:Female; D006801:Humans; D007479:Iopamidol; D007483:Iothalamic Acid / Q000031:analogs & derivatives*; D008297:Male; D009192:Myelography
D003287:Contrast Media; D007483:Iothalamic Acid; D007479:Iopamidol